Ark is trading cautiously towards a retracement of the parabolic Arc, this will give way for a retracement to the levels highlighted.
Much of the bag of ArK's portfolio is made of the pharma and tech sectors which I believe will underperform versus the reopening stocks.
Much of the bag of ArK's portfolio is made of the pharma and tech sectors which I believe will underperform versus the reopening stocks.
Transaction en cours
Transaction en cours:
We are now $12 from first target proposed in March 2021
Trade fermée: cible de profit atteinte:
All targets done
